187 related articles for article (PubMed ID: 24201803)
1. Nuclear NHERF1 expression as a prognostic marker in breast cancer.
Paradiso A; Scarpi E; Malfettone A; Addati T; Giotta F; Simone G; Amadori D; Mangia A
Cell Death Dis; 2013 Nov; 4(11):e904. PubMed ID: 24201803
[TBL] [Abstract][Full Text] [Related]
2. Peritumoral vascular invasion and NHERF1 expression define an immunophenotype of grade 2 invasive breast cancer associated with poor prognosis.
Malfettone A; Saponaro C; Paradiso A; Simone G; Mangia A
BMC Cancer; 2012 Mar; 12():106. PubMed ID: 22439624
[TBL] [Abstract][Full Text] [Related]
3. NHERF1 and tumor microenvironment: a new scene in invasive breast carcinoma.
Saponaro C; Vagheggini A; Scarpi E; Centonze M; Catacchio I; Popescu O; Pastena MI; Giotta F; Silvestris N; Mangia A
J Exp Clin Cancer Res; 2018 May; 37(1):96. PubMed ID: 29716631
[TBL] [Abstract][Full Text] [Related]
4. The cellular distribution of Na+/H+ exchanger regulatory factor 1 is determined by the PDZ-I domain and regulates the malignant progression of breast cancer.
Du G; Gu Y; Hao C; Yuan Z; He J; Jiang WG; Cheng S
Oncotarget; 2016 May; 7(20):29440-53. PubMed ID: 27097111
[TBL] [Abstract][Full Text] [Related]
5. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
[TBL] [Abstract][Full Text] [Related]
6. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
7. Roles of NHERF1/EBP50 in cancer.
Georgescu MM; Morales FC; Molina JR; Hayashi Y
Curr Mol Med; 2008 Sep; 8(6):459-68. PubMed ID: 18781953
[TBL] [Abstract][Full Text] [Related]
8. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells.
Cardone RA; Bellizzi A; Busco G; Weinman EJ; Dell'Aquila ME; Casavola V; Azzariti A; Mangia A; Paradiso A; Reshkin SJ
Mol Biol Cell; 2007 May; 18(5):1768-80. PubMed ID: 17332506
[TBL] [Abstract][Full Text] [Related]
9. NHERF1/EBP50 and NF2 as diagnostic markers for choroid plexus tumors.
Georgescu MM; Mobley BC; Orr BA; Shang P; Lehman NL; Zhu X; O'Neill TJ; Rajaram V; Hatanpaa KJ; Timmons CF; Raisanen JM
Acta Neuropathol Commun; 2016 May; 4(1):55. PubMed ID: 27229317
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling of luminal B breast cancers reveals NHERF1 as a new marker of endocrine resistance.
Karn T; Ruckhäberle E; Hanker L; Müller V; Schmidt M; Solbach C; Gätje R; Gehrmann M; Holtrich U; Kaufmann M; Rody A
Breast Cancer Res Treat; 2011 Nov; 130(2):409-20. PubMed ID: 21203899
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of NHERF1/EBP50 in Clear Cell Renal Cell Carcinoma.
Lema BE; Patricio GM; Kreimann EL
Acta Histochem; 2021 Jul; 123(5):151717. PubMed ID: 33965858
[TBL] [Abstract][Full Text] [Related]
12. Alteration in the sensitivity to crizotinib by Na
Yang F; Hu M; Chang S; Huang J; Si Y; Wang J; Cheng S; Jiang WG
BMC Cancer; 2020 Mar; 20(1):202. PubMed ID: 32164629
[TBL] [Abstract][Full Text] [Related]
13. A Novel NHERF1 Mutation in Human Breast Cancer and Effects on Malignant Progression.
Yang X; Du G; Yu Z; Si Y; Martin TA; He J; Cheng S; Jiang WG
Anticancer Res; 2017 Jan; 37(1):67-73. PubMed ID: 28011475
[TBL] [Abstract][Full Text] [Related]
14. NHERF1: molecular brake on the PI3K pathway in breast cancer.
Georgescu MM
Breast Cancer Res; 2008; 10(2):106. PubMed ID: 18430260
[TBL] [Abstract][Full Text] [Related]
15. NHERF1/EBP50 controls morphogenesis of 3D colonic glands by stabilizing PTEN and ezrin-radixin-moesin proteins at the apical membrane.
Georgescu MM; Cote G; Agarwal NK; White CL
Neoplasia; 2014 Apr; 16(4):365-74.e1-2. PubMed ID: 24862762
[TBL] [Abstract][Full Text] [Related]
16. The scaffolding protein NHERF1 regulates the stability and activity of the tyrosine kinase HER2.
Jeong J; VanHouten JN; Kim W; Dann P; Sullivan C; Choi J; Sneddon WB; Friedman PA; Wysolmerski JJ
J Biol Chem; 2017 Apr; 292(16):6555-6568. PubMed ID: 28235801
[TBL] [Abstract][Full Text] [Related]
17. Na+/H+ exchanger regulatory factor 1 overexpression-dependent increase of cytoskeleton organization is fundamental in the rescue of F508del cystic fibrosis transmembrane conductance regulator in human airway CFBE41o- cells.
Favia M; Guerra L; Fanelli T; Cardone RA; Monterisi S; Di Sole F; Castellani S; Chen M; Seidler U; Reshkin SJ; Conese M; Casavola V
Mol Biol Cell; 2010 Jan; 21(1):73-86. PubMed ID: 19889841
[TBL] [Abstract][Full Text] [Related]
18. Na+/H+ exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells.
Pan Y; Weinman EJ; Dai JL
Breast Cancer Res; 2008; 10(1):R5. PubMed ID: 18190691
[TBL] [Abstract][Full Text] [Related]
19. VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCε-dependent manner.
Alshafie W; Chappe FG; Li M; Anini Y; Chappe VM
Am J Physiol Cell Physiol; 2014 Jul; 307(1):C107-19. PubMed ID: 24788249
[TBL] [Abstract][Full Text] [Related]
20. Direct interaction between NHERF1 and Frizzled regulates β-catenin signaling.
Wheeler DS; Barrick SR; Grubisha MJ; Brufsky AM; Friedman PA; Romero G
Oncogene; 2011 Jan; 30(1):32-42. PubMed ID: 20802536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]